SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023248
Filing Date
2022-11-08
Accepted
2022-11-08 16:20:01
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-20220930.htm   iXBRL 10-Q 3534130
2 EX-10.1 atra-ex10_1.htm EX-10.1 53690
3 EX-10.2 atra-ex10_2.htm EX-10.2 142756
4 EX-10.3 atra-ex10_3.htm EX-10.3 123018
5 EX-31.1 atra-ex31_1.htm EX-31.1 18187
6 EX-31.2 atra-ex31_2.htm EX-31.2 18052
7 EX-32.1 atra-ex32_1.htm EX-32.1 13433
  Complete submission text file 0000950170-22-023248.txt   11294022

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atra-20220930_lab.xml EX-101.LAB 492711
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atra-20220930_pre.xml EX-101.PRE 338049
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atra-20220930_cal.xml EX-101.CAL 62100
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atra-20220930_def.xml EX-101.DEF 170616
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atra-20220930.xsd EX-101.SCH 66186
66 EXTRACTED XBRL INSTANCE DOCUMENT atra-20220930_htm.xml XML 2132240
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 221369201
SIC: 2836 Biological Products, (No Diagnostic Substances)